Salvatore Siena
机构: Università degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, Italy
主页: unimi.it
每年引用次数
引用次数
引用: 86,737
H-指数: 113
I10-指数 : 428
出版物: 995
Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer.
Giulia Bianchi , Sibylle Loibl , Claudio Zamagni , Stefania Salvagni
Anti-Cancer Drugs 20 ( 7) 616 -624
97
2009
Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.
Riccardo Ricotta , Giulio Cerea , Ilaria Schiavetto , Maria Rosaria Maugeri
Future Oncology 2 ( 6) 667 -676
2
2006
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
Bruno Vincenzi , Chiara Cremolini , Andrea Sartore-Bianchi , Antonio Russo
Oncotarget 6 ( 31) 31604 -31612
23
2015
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
Patrizia Comoli , Paolo Pedrazzoli , Rita Maccario , Sabrina Basso
Journal of Clinical Oncology 23 ( 35) 8942 -8949
205
2005
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
Andrea Luciani , Antonio Marra , Luca Toschi , Diego Cortinovis
Clinical Lung Cancer 21 ( 6)
23
2020
Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
S Siena , S Villa , G Bonadonna , M Bregni
Transplantation 43 ( 3) 421 -426
12
1987
O-0014 Effect of Post-Protocol anti-EGFR mAb Therapy on Survival Outcomes in Patients with Wild-Type Kras MCRC Treated with Panitumumab Plus Chemotherapy
Jean-Yves Douillard , Marc Peeters , Alan Rong , Salvatore Siena
Annals of Oncology 23
2012
O-0023 Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (mCRC)
Alberto Sobrero , Axel Grothey , Eric Van Cutsem , Salvatore Siena
Annals of Oncology 23 15 -16
1
2012
PD-0019 Benefit of Panitumumab (pmab) as Monotherapy in Patients with WT KRAS mCRC: A Number-Needed-To-Treat (NNT) Analysis
Eric Van Cutsem , Alan Rong , Yves Humblet , Salvatore Siena
Annals of Oncology 23 25 -25
2012
PD-0023 Benefit of Adding Panitumumab (pmab) To 1St/2Nd-Line Chemotherapy in Patients with KRAS WT mCRC: A Number-Needed-To-Treat (NNT) Analysis
Michel Ducreux , Marc Peeters , Salvatore Siena , Jean-Yves Douillard
Annals of Oncology 23
2012
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor
Daniela Montagna , Ilaria Turin , Roberta Schiavo , Enrica Montini
Cytotherapy 14 ( 1) 80 -90
24
2012
Concurrent Small-Cell Transformation and Emergence of Trans-C797S and T790M Mutations Under Sequential Treatment With EGFR Inhibitors in Lung Adenocarcinoma
Elio G. Pizzutilo , Calogero Lauricella , Giulio Cerea , Laura G. Giannetta
JCO Precision Oncology 2020 ( 3) 1 -5
1
2019
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard , Salvatore Siena , James Cassidy , Josep Tabernero
Journal of Clinical Oncology 28 ( 31) 4697 -4705
1,367
2010
Abstract CT005: Final results of the HERACLES trial in HER2-amplified colorectal cancer
Salvatore Siena , Andrea Sartore-Bianchi , Livio Trusolino , Cosimo Martino
Cancer Research 77
14
2017
Cell-mediated immunity in children with chronic cholestasis.
Giuseppe Maggiore , Costantino De Giacomo , Maria Serenella Scotta , Salvatore Siena
Journal of Pediatric Gastroenterology and Nutrition 1 ( 3) 385 -388
17
1982
Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF
Corrado Tarella , Dario Ferrero , Marco Bregni , Salvatore Siena
European Journal of Cancer and Clinical Oncology 27 ( 1) 22 -27
98
1991
Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF.
Fernando Ravagnani , Salvatore Siena , Marco Bregni , Gianalfredo Sciorelli
European Journal of Cancer and Clinical Oncology 26 ( 5) 562 -564
61
1990
Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy
Marco Bregni , Salvatore Siena , Massimo Di Nicola , Gianni Bonadonna
European Journal of Cancer and Clinical Oncology 27 ( 5) 561 -565
36
1991
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy
Marc Peeters , Salvatore Siena , Eric Van Cutsem , Alberto Sobrero
Cancer 115 ( 7) 1544 -1554
112
2009
Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia.
Paolo Pedrazzoli , Giovanni Rosti , Simona Secondino , Salvatore Siena
Cancer 115 ( 6) 1169 -1173
10
2009